Eversept Partners »

Inmode Ltd. Inmd shares owned by Eversept Partners

Quarter-by-quarter ownership of Inmode Ltd. Inmd (INMD) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Inmode Ltd. Inmd

Tip: Access up to 7 years of quarterly data

All positions including Inmode Ltd. Inmd held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmode Ltd. Inmd by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $910k 62k 14.69

More positions owned by Eversept Partners

Vera Therapeutics Cl A (VERA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
GSK Sponsored Adr (GSK)
United Therapeutics Corporation (UTHR)
Abivax Sa Sponsored Ads (ABVX)
Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Miragen Therapeutics (VRDN)
Vaxcyte (PCVX)
Travere Therapeutics (TVTX)
Hca Holdings (HCA)
Danaher Corporation (DHR)
Ionis Pharmaceuticals (IONS)
Celldex Therapeutics Com New (CLDX)
Bruker Corporation (BRKR)

View all positions for Eversept Partners

Top funds holding Inmode Ltd. Inmd

Doma Perpetual Capital Management
Acadian Asset Management
Renaissance Technologies
BlackRock
Goldman Sachs Group
Susquehanna International
Systematic Financial Management
Ancient Art
Meitav Dash Investments
Harel Insurance Investments & Financial Services
Hotchkis and Wiley Capital Management
Citadel Advisors
Royal Bank of Canada
Millennium Management
D. E. Shaw & Co

View all funds holding Inmode Ltd. Inmd